Extensive Stage Lung Small Cell Carcinoma
Oncology·MeSH: Small Cell Lung Carcinoma
5 drugs in development·2 companies·7 clinical trials
Drug Pipeline by Phase
Phase 2(3)
Phase 1(1)
| Drug | Company |
|---|---|
| Iadademstat | ENANTA PHARMACEUTICALS INC (ENTA) |
Phase 4(1)
| Drug | Company |
|---|---|
| monalizumab | GH Research PLC (GHRS) |
Compare drugs
Frequently asked questions
How many drugs are in development for Extensive Stage Lung Small Cell Carcinoma?
BioSniper tracks 5 drugs in development for Extensive Stage Lung Small Cell Carcinoma across 2 companies.
How many clinical trials target Extensive Stage Lung Small Cell Carcinoma?
There are 7 clinical trials targeting Extensive Stage Lung Small Cell Carcinoma tracked by BioSniper.
Deep-dive into Extensive Stage Lung Small Cell Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis